Clinical Trials for Tumor, Solid

Find clinical trials for tumor, solid. Discover research opportunities and treatment options in your area.

25 Active Trials Found

Showing 25 trials on this page

Page 1 of 2

A Study of PARG Inhibitor XNW29016 in Patients With Advanced Solid Tumors Who Failed Standard Treatment

NCT ID: NCT06987500

This clinical trial is testing a new medication called XNW29016 in patients with advanced solid tumors who have not responded to standard treatments. The main goal is to see if the tablets are safe...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

NW-301 TCR-T in Patients With Advanced Solid Tumor

NCT ID: NCT06956261

This clinical trial, called NW-301, is exploring a new treatment for adults with advanced solid tumors, specifically targeting certain mutations found in cancers like pancreatic, colorectal, and lu...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China, Beijing, Beijing, China

AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors

NCT ID: NCT06911333

This clinical trial is studying a new drug called AD1208 to see how safe it is for people with advanced solid tumors that are not responding to standard treatments. The main goal is to find out the...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of +1 more

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT ID: NCT06022029

This clinical trial is studying a new treatment called ONM-501, which can be given alone or combined with another medication called cemiplimab, for patients with advanced solid tumors and lymphomas...

Recruiting

Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States, Dallas, Texas, United States +14 more

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

NCT ID: NCT03454035

This clinical trial is investigating a combination of two medications, ulixertinib and palbociclib, to see if they are safe and to find the best dose for patients with advanced pancreatic cancer an...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chapel Hill, North Carolina, United States

Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

NCT ID: NCT06798532

This clinical trial is studying whether using a special imaging test called arteriography before surgery can help identify a critical blood vessel, known as the Adamkiewicz artery, in patients with...

Not yet recruiting

Type: observational Locations: Caen, , France, Grenoble, , France +25 more

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

NCT ID: NCT06090266

This clinical trial is studying a new treatment called OR502, which is a type of medicine known as a monoclonal antibody. It targets a specific molecule on cancer cells and is being tested alone an...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Antonio, Texas, United States, Austin, Texas, United States +2 more

LEU01101: Safety and Preliminary Efficacy of LEU011 in Solid Tumours.

NCT ID: NCT06193902

The LEU01101 trial is a clinical study aimed at testing a new treatment called LEU011, which uses a type of immune cell therapy known as CAR T cells to target certain proteins found on solid tumors...

Recruiting

Phase: PHASE1 Type: interventional Locations: Manchester, , United Kingdom, London, , United Kingdom

Standardized Nutritional Management of Pediatric Patients With Solid Tumors

NCT ID: NCT06730204

This clinical trial is looking at how standardized nutrition plans can help improve the health of children diagnosed with solid tumors, which are a type of cancer. The goal is to find the best ways...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, Shanghai, China

Immune Profiling for Cancer Immunotherapy Response

NCT ID: NCT06116032

This clinical trial, called "Immune Profiling for Cancer Immunotherapy Response," is studying how certain immune markers in the body can help predict how well cancer treatments work. Specifically, ...

Recruiting

Type: observational Locations: Lebanon, New Hampshire, United States

TumorGlow Intraoperative Molecular Imaging (IMI)

NCT ID: NCT04723810

The TumorGlow Intraoperative Molecular Imaging (IMI) trial is a research study designed to help doctors better see and treat solid tumors during surgery. This study is looking at how safe and effec...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States

Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan)

NCT ID: NCT06347731

The Varian ProBeam360° Proton Therapy System clinical trial in Wuhan is testing a new type of radiation therapy for patients with solid tumors. The goal of the study is to see how effective and saf...

Recruiting

Phase: NA Type: interventional Locations: Wuhan, Hubei, China

NW-301 TCR-T in Patients With Advanced Solid Tumor

NCT ID: NCT06484556

This clinical trial, called NW-301, is investigating a new treatment for patients with advanced solid tumors, specifically those with certain types of cancer that have a specific gene mutation know...

Recruiting

Phase: PHASE1 Type: interventional Locations: Wuhan, Hubei, China

NW-301 TCR-T in Patients With Advanced Solid Tumor

NCT ID: NCT06484790

This clinical trial, called NW-301, is exploring a new treatment using specially modified immune cells to help patients with advanced solid tumors, such as pancreatic, colorectal, or lung cancer. T...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tianjin, , China

NW-301 TCR-T in Patients With Advanced Solid Tumor

NCT ID: NCT06478251

This clinical trial, called NW-301, is exploring a new treatment for patients with advanced solid tumors, specifically those with pancreatic or colorectal cancer that have not responded to standard...

Recruiting

Phase: PHASE1 Type: interventional Locations: Hangzhou, , China

A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors

NCT ID: NCT06431529

This clinical trial is exploring a new treatment option for patients with advanced solid tumors, like ovarian cancer, non-small cell lung cancer, and colorectal cancer. The study aims to see if spe...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Nanjing, Jiangsu, China

Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery

NCT ID: NCT05943119

This clinical trial is studying a type of radiation therapy called intensity-modulated radiotherapy (IMRT) to treat sinus cancers after patients have had surgery to remove the tumor. The researcher...

Recruiting

Phase: PHASE2 Type: interventional Locations: Caen, , France, Lille, , France +1 more

A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab

NCT ID: NCT05378425

This clinical trial is studying a new treatment called NTX-1088, which is a type of medicine known as a monoclonal antibody. This treatment targets a specific protein found on certain cancer cells,...

Recruiting

Phase: PHASE1 Type: interventional Locations: New Orleans, Louisiana, United States, Duarte, California, United States +3 more

Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment

NCT ID: NCT05661461

This clinical trial is studying a medication called nab-sirolimus to see how safe it is and how the body processes it in patients with advanced solid tumors and moderate liver impairment. It is a P...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Antonio, Texas, United States, West Valley City, Utah, United States

PET Imaging of 68Ga-NOTA-H006 in Malignancy

NCT ID: NCT06162988

This clinical trial is studying a new imaging agent called 68Ga-NOTA-H006, which helps doctors see certain types of cancer better. The focus is on a protein called 5T4, which is found in high amoun...

Not yet recruiting

Phase: NA Type: interventional Locations: Shanghai, Shanghai, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions